SUMMIT, N.J. – IgX Corp., a developer of drugs for the treatment of infectious diseases of the human gastrointestinal tract, filed to go public September 30. The company is offering 2.3 million shares at between $8 and $10 each. The initial public offering will leave 8.97 million shares of common stock outstanding. The underwriter for […]
NEW YORK – EarthWeb Inc., a provider of Internet-based online services to the information technology community, went public November 10, offering 2.1 million shares at $14 apiece. Stocks priced at the high end of the company’s $12 to $14 filing range. The initial public offering, which left 7.9 million shares outstanding, was underwritten by J.P. […]
James Cavanaugh, a general partner at HealthCare Ventures L.P., has no intention of becoming a mutual fund manager, but he and his colleagues are spending a good deal of their time looking at public companies. Focused on biopharmaceuticals, the New Jersey and Massachusetts-based venture firm hopes to take advantage of the drubbing micro-cap life-sciences stocks […]
Kevin Appelbaum came to a realization in mid-1997: he was purchasing all of his airline tickets online and found himself reading more books because of Amazon.com. “If I could avoid going to the store by going online and finding what I needed, I was doing it,” says the entrepreneur, who at the time worked with […]